A Study of LY3053102 in Healthy Participants

NCT01736241 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY3053102
DRUG: Placebo

Sponsor

Eli Lilly and Company